Igenbio, Inc.

Igenbio, Inc. (Integrated Genomics™), founded in 2013, operates in the Biotechnology and Health Care industries. The company aims to transform ‘omics information into actionable knowledge, enabling organizations to develop bio-products more efficiently. Igenbio provides a range of products and services for research in microbial genomics, biochemistry, and gene expression, all of which are supported by their web-based genome analysis platform, ERGO™. This platform integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information, offering superior and expedited identification of gene function across all organisms. The company's expertise stems from its scientists' extensive experience in in silico and wet lab sequencing, research, and development, reflected in over 100 relevant publications in these areas. Notably, Igenbio has established relationships and conducted active research in the areas of lactic acid bacteria and pathogenic microbes, catering to a broad customer base across industry, academic, and government institutions. The precise headquarter location, last investment, and associated investors are not currently available.